AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Director's Dealing Jan 16, 2020

7734_dirs_2020-01-16_b2457046-c819-4916-bc9d-315473cece85.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0782A

Judges Scientific PLC

16 January 2020

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Exercise of Options and Director dealing

The Company has today issued 20,000 new ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options at a price of £14.38 under the Company's Unapproved Share Option Scheme. The new Ordinary Shares are being issued under the Company's current blocklisting.

The options were exercised by the Group Finance Director, Brad Ormsby. They were granted when he joined the Company in April 2015.  He has today also sold 19,000 Ordinary Shares at £49.75 per Ordinary Share, partially to finance the cost of exercising the options, the resulting income tax and employer's National Insurance liabilities.  

Following the exercise and sale, Brad Ormsby's holding in the Company has increased by 1,000 Ordinary Shares and therefore his resulting interest in the Company has increased to 3,680 Ordinary Shares representing 0.06 per cent. of the issued Ordinary share capital.  In addition, he holds remaining options of 10,000 Ordinary Shares under the Company's Unapproved Share Option Scheme.

Following the allotment of these shares, the enlarged issued Ordinary share capital will be 6,246,091 Ordinary Shares.

For further information please contact:

Judges Scientific
David Cicurel, CEO

Brad Ormsby, Group FD
Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Broker)
Stephane Auton

Edward Mansfield

Sarah Mather
Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

Media enquiries:

Alma PR (Financial Public Relations)
Tel : +44 (0) 20 3100 2222
Rebecca Sanders-Hewett

Sam Modlin
Tel: +44 (0) 20 3865 4219

[email protected]

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bradley Ormsby

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Judges Scientific plc

b)

LEI

2138004EXWWPTW1JOL31

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Judges Scientific plc

GB0032398678

b)

Nature of the transaction

Exercise of options and subsequent sale of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
1437.5p 20,000
4975.0p 19,000

d)

Aggregated information

- Aggregated volume

- Price

N/A (two separate single transactions

e)

Date of the transaction

16/01/2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHUNAVRRNUAAAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.